Patent details

Basic Information

Publication number:

EP2905030

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP151566478

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Human antibodies that bind lymphocyte activation gene-3 (LAG-3) and uses thereof

French Title of Invention:

Anticorps humains qui se lient à l'activation des lymphocytes gène-3 (lag-3) et leurs utilisations

German Title of Invention:

Lymphozytenaktivierungsgen-3 (LAG-3) bindende humane Antikörper und ihre Verwendung

SPC Number:

Dates

Filing date:

11/08/2009

Grant date:

06/11/2019

EP Publication Date:

12/08/2015

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

06/11/2019

EP B1 Publication Date:

06/11/2019

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

11/08/2029

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

30/10/2019

 

 

Name:

E. R. Squibb & Sons, L.L.C.

Address:

Route 206 & Province Line Road, Princeton, NJ 08540, United States (US)

Agent

Name:

MARKS & CLERK LLP

From:

16/12/2019

Address:

BP 1775, 1017, LUXEMBOURG, Luxembourg (LU)

To:

Inventor

1

Name:

Selby, Mark

Address:

United States (US)

2

Name:

Thudium, Kent B.

Address:

United States (US)

3

Name:

Korman, Alan J.

Address:

United States (US)

4

Name:

Leblanc, Heidi

Address:

United States (US)

5

Name:

Zens, Kyra, D.

Address:

United States (US)

6

Name:

Yamanaka, Mark

Address:

United States (US)

Priority

Priority Number:

188548 P

Priority Date:

11/08/2008

Priority Country:

United States (US)

Classification

IPC classification:

A61K 39/00; A61K 39/395; A61K 51/10; C07K 16/28; C07K 17/00;

Publication

European Patent Bulletin

Issue number:

201945

Publication date:

06/11/2019

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

01/09/2025

Annual Fee Number:

17

Annual Fee Amount:

246 Euro

Expected Payer:

Last Annual Fee Payment Date:

26/07/2024

Last Annual Fee Paid Number:

16

Last Annual Fee Paid Amount:

230 Euro

Payer:

CPA GLOBAL THE IP PLATFORM

Filing date	Document type	Number of pages
16/12/2019	Outgoing Correspondence	1
16/12/2019	Power Of Attorney	1
12/08/2022	Request For Change	1
02/09/2022	Outgoing Correspondence	56